HOME >> BIOLOGY >> NEWS
Leading experts in field of gene therapy to meet in Minneapolis

The leading experts in the field of gene therapy will gather in Minneapolis, June 2-6, 2004, for the 7th Annual Meeting of the American Society of Gene Therapy (ASGT). New developments on the use of gene therapy for treating infections diseases such as cancer and AIDS, cardiovascular diseases, and cystic fibrosis will be showcased in a variety of educational workshops and symposia.

Program topics will also feature:

  • Innovative approaches of gene therapy
  • Long term follow up of gene therapy clinical trials
  • International harmonization of regulatory standards for clinical trials

Gordon Keller, MD, Mount Sinai School of Medicine, and Catherine Verfaillie, MD, University of Minnesota Health Center, will present the Presidential Symposium lecture. In addition, the premier George Stamatoyannopoulos lecture will be given by Harriet Robinson, MD, from the Yerkes Regional Primate Research Center.

Members of the media may register without charge for the ASGT 7th Annual Meeting. Press conferences on the latest research will be conducted throughout the meeting. A press room with interview space, computers, modem lines, telephone and facsimile services will also be available onsite for media representatives. To receive an annual meeting preliminary program, press conference schedule, or registration materials, contact John Gardner at 414-278-1341 or jgardner@execinc.com.

The ASGT is the largest medical professional organizations representing researchers and scientists dedicated to discovering new gene therapies. Established in 1996, the ASGT has grown to nearly 3,000 members. ASGT is committed to promoting and fostering the exchange and dissemination of information and ideas related to gene therapy and encouraging the general field of research.

For more information, contact John Gardner at 414/278-1341 or visit www.asgt.org


'"/>

Contact: John Gardner
jgardner@execinc.com
414-278-1341
American Academy of Allergy, Asthma & Immunology
5-Apr-2004


Page: 1

Related biology news :

1. Leading scientists design new framework for biodiversity conservation
2. Leading science, higher-education and engineering groups urge six improvements to U.S. visa quagmire
3. Leading U.S. gun manufacturer joins NJIT to develop personalized handgun
4. Leading bacterial pathogen is sequenced
5. Leading cloning experts challenge Clonaid to prove claim
6. Leading cancer research organization urges FDA to speed approval of drugs for precancers
7. Leading lab expert to update medical community on diagnostic testing for thyroid function
8. Leading indoor environment experts to convene at Syracuse University to discuss air quality and urban environments
9. Leading snake expert dies at 38
10. Leading experts address safety and economics of biotech crops
11. Taking the show on the road - Leading researchers to conduct hands-on science symposium for 500 San Francisco area high school students

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Leading experts field gene therapy meet Minneapolis

(Date:7/2/2015)... June 25, 2015 ... addition of the "Natural Language Processing Market ... IVR, OCR, Pattern & Image Recognition) - Worldwide ... The key vendors occupying the market ... Corporation, Microsoft Corporation, NetBase Solutions, SAS Institute Inc., ...
(Date:7/2/2015)... , June 25, 2015 ... of the "Next Generation Biometrics Market by Application, ... report to their offering. The next ... by 2020, at a CAGR of 17.9% between 2015 ... leading application for the market. Safran SA ...
(Date:7/2/2015)... , July 2, 2015 Fingerprint Cards ... FPC1035, FPC1145 and FPC1155 from the distributor World Peace Industrial ... FPC,s distributors in Asia . Deliveries are ... sensors will be used by smartphone manufacturers in ... included in the communicated revenue guidance of approximately 2,200 MSEK ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
(Date:7/6/2015)... -- Research and Markets ( ... "Biotechnology for the Non-Biotechnologist" conference to ... ideal for non-Scientists and Scientists needing to understand ... biotechnology. Ideal for Non-Scientists and Scientists ... and potential of biotechnology Why you ...
(Date:7/6/2015)... 6, 2015  Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company ... , Viveve,s Chief Executive Officer, and Scott Durbin , ... July 9, 2015. , , , DATE:    ... , , TIME:     , , , 12:15 PM ... , http://tinyurl.com/viveve   ,    ...
(Date:7/6/2015)... PRINCETON, N.J. , July 6, 2015 Navitas, a leading ... Latin America hub in Bogota, Colombia ... advantage of the many benefits provided by Colombia , ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... location, allows US based clients to communicate with Navitas regulatory ...
(Date:7/6/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... Novella Clinical (Novella), to conduct the phase 3 ... glioblastoma. Novella is a full-service, global clinical research organization ... oncology companies. The ICT-107 phase 3 trial will include ... Europe and Canada , ...
Breaking Biology Technology:Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2
Cached News: